Why is Kwality Pharma falling/rising?

As of 18-Jul, Kwality Pharmaceuticals Ltd is currently priced at 1,164.40, reflecting a decrease of 17.45 points or 1.48%. The stock has underperformed its sector today by 0.93%, with an intraday low of Rs 1155.05, indicating a decline of 2.27%. Over the past week, the stock has decreased by 1.48%, while it has shown a strong performance over the last month with an increase of 8.80%. Despite positive long-term growth indicators, such as a 241.51% increase in net profit and consistent positive results over the last five quarters, the company faces challenges with a negative annual growth rate in net sales and operating profit over the past five years. Additionally, the low participation from domestic mutual funds may signal concerns about the stock's valuation and future growth potential.
In the broader market context, the stock's recent decline contrasts with the Sensex, which has only decreased by 0.90% over the same week. While Kwality Pharmaceuticals has outperformed the benchmark in the long term, generating a 131.95% return over the past year compared to the Sensex's 0.51%, the current short-term performance suggests a divergence from this trend. The stock's higher moving averages indicate a generally positive trend, but the recent drop in delivery volume and the expensive valuation relative to its peers may contribute to investor caution. Overall, the combination of strong historical performance and current negative indicators is influencing the stock's recent price movement.